In Canada, Oligo Medic, a medical device company that develops biomaterials for regenerative medicine and is known for JointRep for cartilage treatment in body joints, has a new CEO, Jerett A. Creed. Creed’s career started with Johnson and Johnson focusing on angioplasty balloons and metal stents, as CFO of a publicly traded oil and gas company and CEO of Cardigant Medical, but has evolved with his 20 years of experience in the medical technology field. Creed led Oligo Medic’s launch of their JointRep product in Latin America. He has also been involved in 2 public offerings as well as more than $650 million merger and acquisition activities for Oligo Medic.
Latest article
Plant-based artificial Christmas trees set to launch this December
In California, artificial Christmas tree maker Balsam Brands will launch a new line of trees for 2025’s holiday season that use needles made of...
Artist Sam Shoemaker takes mushroom kayak on twelve-hour journey
In California, an artist and “mycologist” has crossed 26 miles of ocean in a kayak made of mycelium, the root system of mushrooms.
Sam...
Canadian funeral group becomes first to offer Loop’s mycelium coffins and urns
In Canada, Mount Pleasant Group’s Meadowvale Cemetery, Funeral and Cremation Centres have become the first in Canada to offer the Loop Living Cocoon and...